DQ 65–79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation 1
暂无分享,去创建一个
[1] A. Krensky,et al. DQ 65–79, a Peptide Derived from HLA Class II, Induces IκB Expression1 , 2002, The Journal of Immunology.
[2] G. Dotto,et al. p21(WAF1/Cip1): more than a break to the cell cycle? , 2000, Biochimica et biophysica acta.
[3] Z. Jónsson,et al. A Direct Interaction between Proliferating Cell Nuclear Antigen (PCNA) and Cdk2 Targets PCNA-interacting Proteins for Phosphorylation* , 2000, The Journal of Biological Chemistry.
[4] B. Hoffman,et al. Characterization of MyD118, Gadd45, and Proliferating Cell Nuclear Antigen (PCNA) Interacting Domains , 2000, The Journal of Biological Chemistry.
[5] D. Lane,et al. A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics. , 2000, Biochemistry.
[6] A. Krensky,et al. A human class II MHC-derived peptide antagonizes phosphatidylinositol 3-kinase to block IL-2 signaling. , 2000, The Journal of clinical investigation.
[7] K. Ball,et al. Reversible Phosphorylation at the C-terminal Regulatory Domain of p21Waf1/Cip1 Modulates Proliferating Cell Nuclear Antigen Binding* , 2000, The Journal of Biological Chemistry.
[8] T. Tanaka,et al. Intranuclear localization of proliferating cell nuclear antigen during the cell cycle in renal cell carcinoma. , 2000, Analytical and quantitative cytology and histology.
[9] T. Tsurimoto. PCNA binding proteins. , 1999, Frontiers in bioscience : a journal and virtual library.
[10] R. Sikorski,et al. A p21(Waf1/Cip1)carboxyl-terminal peptide exhibited cyclin-dependent kinase-inhibitory activity and cytotoxicity when introduced into human cells. , 1999, Cancer research.
[11] V. Bohr,et al. The C-terminal domain of p21 inhibits nucleotide excision repair In vitro and In vivo. , 1999, Molecular biology of the cell.
[12] A. Krensky,et al. HLA-derived peptides as novel immunomodulatory therapeutics. , 1999, Journal of the American Society of Nephrology : JASN.
[13] H. Snoeck,et al. Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis. , 1999, The Journal of clinical investigation.
[14] T. Tsurimoto. PCNA, a multifunctional ring on DNA. , 1998, Biochimica et biophysica acta.
[15] Z. Kelman,et al. Protein-PCNA interactions: a DNA-scanning mechanism? , 1998, Trends in biochemical sciences.
[16] A. Krensky,et al. Inhibition of cell cycle progression by a synthetic peptide corresponding to residues 65-79 of an HLA class II sequence: functional similarities but mechanistic differences with the immunosuppressive drug rapamycin. , 1998, Journal of immunology.
[17] R. DePinho,et al. Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] Bernard Ducommun,et al. p21 binding to PCNA causes G1 and G2 cell cycle arrest in p53-deficient cells , 1998, Oncogene.
[19] H. Ng,et al. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. , 1997, Science.
[20] D. Lane,et al. Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair , 1997, Oncogene.
[21] M. Broggini,et al. p21WAF1-derived peptides linked to an internalization peptide inhibit human cancer cell growth. , 1997, Cancer research.
[22] Z. Kelman. PCNA: structure, functions and interactions , 1997, Oncogene.
[23] C. Smythe,et al. Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1 , 1997, Current Biology.
[24] W. Sellers,et al. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors , 1996, Molecular and cellular biology.
[25] John Kuriyan,et al. Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA , 1996, Cell.
[26] Anindya Dutta,et al. Cyclin-binding motifs are essential for the function of p21CIP1 , 1996, Molecular and cellular biology.
[27] Anindya Dutta,et al. A 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo. , 1996, Nucleic acids research.
[28] J. Hurwitz,et al. Inhibition of Nucleotide Excision Repair by the Cyclin-dependent Kinase Inhibitor p21 (*) , 1995, The Journal of Biological Chemistry.
[29] M. Nakanishi,et al. The C-terminal Region of p21 Is Involved in Proliferating Cell Nuclear Antigen Binding but Does Not Appear to Be Required for Growth Inhibition (*) , 1995, The Journal of Biological Chemistry.
[30] U. Hübscher,et al. Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. , 1995, Biochemistry.
[31] B. Ducommun,et al. Identification of binding domains on the p21Cip1 cyclin-dependent kinase inhibitor. , 1995, Oncogene.
[32] M. Kirschner,et al. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.
[33] D. Lane,et al. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen , 1995, Current Biology.
[34] M. Sayegh,et al. Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides. , 1995, Transplantation proceedings.
[35] A. Nomura,et al. Nuclear distribution of proliferating cell nuclear antigen (PCNA) in fertilized eggs of the starfish Asterina pectinifera. , 1994, Journal of cell science.
[36] P. O'Connor,et al. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. , 1994, Science.
[37] S. Elledge,et al. Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Hannon,et al. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA , 1994, Nature.
[39] A. Krensky,et al. Induction of allograft tolerance in rats by an HLA class-I-derived peptide and cyclosporine A. , 1994, Journal of immunology.
[40] S. Matsuoka,et al. D-type cyclin-binding regions of proliferating cell nuclear antigen. , 1994, The Journal of biological chemistry.
[41] J. R. Smith,et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.
[42] J. Fechner,et al. Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. , 1994, Journal of immunology.
[43] C. Turck,et al. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit , 1993, Nature.
[44] David Beach,et al. p21 is a universal inhibitor of cyclin kinases , 1993, Nature.
[45] S. Elledge,et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases , 1993, Cell.
[46] J. Trent,et al. WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.
[47] D. Beach,et al. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. , 1993, Molecular biology of the cell.
[48] D. Shoskes,et al. Induction of specific unresponsiveness using transfected cells expressing donor major histocompatibility complex molecules: evidence for indirect presentation of allopeptides in vivo. , 1993, Transplantation proceedings.
[49] M. Mathews,et al. Regulation of proliferating cell nuclear antigen during the cell cycle. , 1989, The Journal of biological chemistry.
[50] R. Superina,et al. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes , 1988, Nature.
[51] P. Parham,et al. Inhibition of alloreactive cytotoxic T lymphocytes by peptides from the α2 domain of HLA–A2 , 1987, Nature.
[52] J. Strominger,et al. Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[53] D O Morgan,et al. Cyclin-dependent kinases: engines, clocks, and microprocessors. , 1997, Annual review of cell and developmental biology.
[54] A. Krensky,et al. Peptides corresponding to T-cell receptor-HLA contact regions inhibit class I-restricted immune responses. , 1993, Transplantation proceedings.
[55] P. Parham,et al. HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes , 1987, Nature.